Where Will The Trade Desk’s Stock Be in 5 Years?
If you stitched together every advertisement The Trade Desk (NASDAQ:…
Sell
47
ELV Quote, Financials, Valuation and Earnings
Last price:
$387.47
Seasonality move
:
-0.45%
Day range:
$376.69 - $386.41
52-week range:
$357.45 - $567.26
Dividend yield:
1.73%
P/E ratio:
15.07x
P/S ratio:
0.49x
P/B ratio:
2.05x
Volume:
898K
Avg. volume:
1.8M
1-year change:
-27.21%
Market cap:
$87.3B
Revenue:
$176.8B
EPS (TTM):
$25.63
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
ELV
Elevance Health
|
$46.2B | $11.48 | 10.81% | -3.97% | $500.75 |
|
CI
The Cigna Group
|
$60.4B | $6.35 | 3.55% | 30.86% | $375.34 |
|
CLOV
Clover Health Investments
|
$466.9M | -$0.07 | 31.45% | 200% | $4.69 |
|
CNC
Centene
|
$43.2B | $2.52 | 12.25% | -5.01% | $76.50 |
|
MOH
Molina Healthcare
|
$10.8B | $5.96 | 10.82% | 19.82% | $359.49 |
|
UNH
UnitedHealth Group
|
$111.6B | $7.29 | 13.15% | 11% | $385.34 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
ELV
Elevance Health
|
$386.22 | $500.75 | $87.3B | 15.07x | $1.71 | 1.73% | 0.49x |
|
CI
The Cigna Group
|
$315.37 | $375.34 | $84.2B | 17.46x | $1.51 | 1.85% | 0.35x |
|
CLOV
Clover Health Investments
|
$2.93 | $4.69 | $1.5B | -- | $0.00 | 0% | 0.97x |
|
CNC
Centene
|
$55.38 | $76.50 | $27.6B | 8.25x | $0.00 | 0% | 0.17x |
|
MOH
Molina Healthcare
|
$293.48 | $359.49 | $15.9B | 14.17x | $0.00 | 0% | 0.40x |
|
UNH
UnitedHealth Group
|
$318.50 | $385.34 | $288.9B | 13.34x | $2.10 | 2.64% | 0.72x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
ELV
Elevance Health
|
41.38% | -0.126 | 30.53% | 2.01x |
|
CI
The Cigna Group
|
43.08% | 0.136 | 34.23% | 0.81x |
|
CLOV
Clover Health Investments
|
-- | 0.612 | -- | 1.38x |
|
CNC
Centene
|
39.62% | -0.216 | 60.45% | 1.07x |
|
MOH
Molina Healthcare
|
45.33% | -0.770 | 20.09% | 1.57x |
|
UNH
UnitedHealth Group
|
46.1% | -0.103 | 16.7% | 0.77x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
ELV
Elevance Health
|
-- | -- | 8.37% | 14.03% | 6.43% | $821M |
|
CI
The Cigna Group
|
-- | -- | 6.86% | 12.17% | 3.07% | $1.6B |
|
CLOV
Clover Health Investments
|
$108.9M | -$1.3M | -7.67% | -7.67% | -0.28% | -$16.5M |
|
CNC
Centene
|
$5.2B | $1.5B | 7.62% | 12.65% | 4.11% | $1.4B |
|
MOH
Molina Healthcare
|
$1.3B | $433M | 16.29% | 25.66% | 3.89% | $168M |
|
UNH
UnitedHealth Group
|
$23.8B | $9.1B | 12.37% | 21.74% | 8.31% | $4.6B |
Elevance Health vs. Competitors
-
Which has Higher Returns ELV or CI?
The Cigna Group has a net margin of 4.47% compared to Elevance Health's net margin of 2.02%. Elevance Health's return on equity of 14.03% beat The Cigna Group's return on equity of 12.17%.
Company Gross Margin Earnings Per Share Invested Capital ELVElevance Health-- $9.61 $72.6B CIThe Cigna Group-- $4.85 $70.9B -
What do Analysts Say About ELV or CI?
Elevance Health has a consensus price target of $500.75, signalling upside risk potential of 29.66%. On the other hand The Cigna Group has an analysts' consensus of $375.34 which suggests that it could grow by 19.02%. Given that Elevance Health has higher upside potential than The Cigna Group, analysts believe Elevance Health is more attractive than The Cigna Group.
Company Buy Ratings Hold Ratings Sell Ratings ELVElevance Health13 4 0 CIThe Cigna Group13 6 0 -
Is ELV or CI More Risky?
Elevance Health has a beta of 0.603, which suggesting that the stock is 39.674% less volatile than S&P 500. In comparison The Cigna Group has a beta of 0.437, suggesting its less volatile than the S&P 500 by 56.294%.
-
Which is a Better Dividend Stock ELV or CI?
Elevance Health has a quarterly dividend of $1.71 per share corresponding to a yield of 1.73%. The Cigna Group offers a yield of 1.85% to investors and pays a quarterly dividend of $1.51 per share. Elevance Health pays 25.22% of its earnings as a dividend. The Cigna Group pays out 45.63% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios ELV or CI?
Elevance Health quarterly revenues are $48.9B, which are smaller than The Cigna Group quarterly revenues of $65.5B. Elevance Health's net income of $2.2B is higher than The Cigna Group's net income of $1.3B. Notably, Elevance Health's price-to-earnings ratio is 15.07x while The Cigna Group's PE ratio is 17.46x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Elevance Health is 0.49x versus 0.35x for The Cigna Group. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ELVElevance Health0.49x 15.07x $48.9B $2.2B CIThe Cigna Group0.35x 17.46x $65.5B $1.3B
-
Which has Higher Returns ELV or CLOV?
Clover Health Investments has a net margin of 4.47% compared to Elevance Health's net margin of -0.28%. Elevance Health's return on equity of 14.03% beat Clover Health Investments's return on equity of -7.67%.
Company Gross Margin Earnings Per Share Invested Capital ELVElevance Health-- $9.61 $72.6B CLOVClover Health Investments23.55% -- $336.1M -
What do Analysts Say About ELV or CLOV?
Elevance Health has a consensus price target of $500.75, signalling upside risk potential of 29.66%. On the other hand Clover Health Investments has an analysts' consensus of $4.69 which suggests that it could grow by 59.98%. Given that Clover Health Investments has higher upside potential than Elevance Health, analysts believe Clover Health Investments is more attractive than Elevance Health.
Company Buy Ratings Hold Ratings Sell Ratings ELVElevance Health13 4 0 CLOVClover Health Investments2 2 0 -
Is ELV or CLOV More Risky?
Elevance Health has a beta of 0.603, which suggesting that the stock is 39.674% less volatile than S&P 500. In comparison Clover Health Investments has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock ELV or CLOV?
Elevance Health has a quarterly dividend of $1.71 per share corresponding to a yield of 1.73%. Clover Health Investments offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Elevance Health pays 25.22% of its earnings as a dividend. Clover Health Investments pays out -- of its earnings as a dividend. Elevance Health's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios ELV or CLOV?
Elevance Health quarterly revenues are $48.9B, which are larger than Clover Health Investments quarterly revenues of $462.3M. Elevance Health's net income of $2.2B is higher than Clover Health Investments's net income of -$1.3M. Notably, Elevance Health's price-to-earnings ratio is 15.07x while Clover Health Investments's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Elevance Health is 0.49x versus 0.97x for Clover Health Investments. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ELVElevance Health0.49x 15.07x $48.9B $2.2B CLOVClover Health Investments0.97x -- $462.3M -$1.3M
-
Which has Higher Returns ELV or CNC?
Centene has a net margin of 4.47% compared to Elevance Health's net margin of 2.81%. Elevance Health's return on equity of 14.03% beat Centene's return on equity of 12.65%.
Company Gross Margin Earnings Per Share Invested Capital ELVElevance Health-- $9.61 $72.6B CNCCentene11.16% $2.63 $46.3B -
What do Analysts Say About ELV or CNC?
Elevance Health has a consensus price target of $500.75, signalling upside risk potential of 29.66%. On the other hand Centene has an analysts' consensus of $76.50 which suggests that it could grow by 38.14%. Given that Centene has higher upside potential than Elevance Health, analysts believe Centene is more attractive than Elevance Health.
Company Buy Ratings Hold Ratings Sell Ratings ELVElevance Health13 4 0 CNCCentene7 10 0 -
Is ELV or CNC More Risky?
Elevance Health has a beta of 0.603, which suggesting that the stock is 39.674% less volatile than S&P 500. In comparison Centene has a beta of 0.453, suggesting its less volatile than the S&P 500 by 54.716%.
-
Which is a Better Dividend Stock ELV or CNC?
Elevance Health has a quarterly dividend of $1.71 per share corresponding to a yield of 1.73%. Centene offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Elevance Health pays 25.22% of its earnings as a dividend. Centene pays out -- of its earnings as a dividend. Elevance Health's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios ELV or CNC?
Elevance Health quarterly revenues are $48.9B, which are larger than Centene quarterly revenues of $46.6B. Elevance Health's net income of $2.2B is higher than Centene's net income of $1.3B. Notably, Elevance Health's price-to-earnings ratio is 15.07x while Centene's PE ratio is 8.25x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Elevance Health is 0.49x versus 0.17x for Centene. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ELVElevance Health0.49x 15.07x $48.9B $2.2B CNCCentene0.17x 8.25x $46.6B $1.3B
-
Which has Higher Returns ELV or MOH?
Molina Healthcare has a net margin of 4.47% compared to Elevance Health's net margin of 2.67%. Elevance Health's return on equity of 14.03% beat Molina Healthcare's return on equity of 25.66%.
Company Gross Margin Earnings Per Share Invested Capital ELVElevance Health-- $9.61 $72.6B MOHMolina Healthcare11.48% $5.45 $7.9B -
What do Analysts Say About ELV or MOH?
Elevance Health has a consensus price target of $500.75, signalling upside risk potential of 29.66%. On the other hand Molina Healthcare has an analysts' consensus of $359.49 which suggests that it could grow by 22.49%. Given that Elevance Health has higher upside potential than Molina Healthcare, analysts believe Elevance Health is more attractive than Molina Healthcare.
Company Buy Ratings Hold Ratings Sell Ratings ELVElevance Health13 4 0 MOHMolina Healthcare6 8 0 -
Is ELV or MOH More Risky?
Elevance Health has a beta of 0.603, which suggesting that the stock is 39.674% less volatile than S&P 500. In comparison Molina Healthcare has a beta of 0.564, suggesting its less volatile than the S&P 500 by 43.589%.
-
Which is a Better Dividend Stock ELV or MOH?
Elevance Health has a quarterly dividend of $1.71 per share corresponding to a yield of 1.73%. Molina Healthcare offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Elevance Health pays 25.22% of its earnings as a dividend. Molina Healthcare pays out -- of its earnings as a dividend. Elevance Health's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios ELV or MOH?
Elevance Health quarterly revenues are $48.9B, which are larger than Molina Healthcare quarterly revenues of $11.1B. Elevance Health's net income of $2.2B is higher than Molina Healthcare's net income of $298M. Notably, Elevance Health's price-to-earnings ratio is 15.07x while Molina Healthcare's PE ratio is 14.17x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Elevance Health is 0.49x versus 0.40x for Molina Healthcare. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ELVElevance Health0.49x 15.07x $48.9B $2.2B MOHMolina Healthcare0.40x 14.17x $11.1B $298M
-
Which has Higher Returns ELV or UNH?
UnitedHealth Group has a net margin of 4.47% compared to Elevance Health's net margin of 5.74%. Elevance Health's return on equity of 14.03% beat UnitedHealth Group's return on equity of 21.74%.
Company Gross Margin Earnings Per Share Invested Capital ELVElevance Health-- $9.61 $72.6B UNHUnitedHealth Group21.7% $6.85 $186.4B -
What do Analysts Say About ELV or UNH?
Elevance Health has a consensus price target of $500.75, signalling upside risk potential of 29.66%. On the other hand UnitedHealth Group has an analysts' consensus of $385.34 which suggests that it could grow by 20.99%. Given that Elevance Health has higher upside potential than UnitedHealth Group, analysts believe Elevance Health is more attractive than UnitedHealth Group.
Company Buy Ratings Hold Ratings Sell Ratings ELVElevance Health13 4 0 UNHUnitedHealth Group13 6 1 -
Is ELV or UNH More Risky?
Elevance Health has a beta of 0.603, which suggesting that the stock is 39.674% less volatile than S&P 500. In comparison UnitedHealth Group has a beta of 0.442, suggesting its less volatile than the S&P 500 by 55.841%.
-
Which is a Better Dividend Stock ELV or UNH?
Elevance Health has a quarterly dividend of $1.71 per share corresponding to a yield of 1.73%. UnitedHealth Group offers a yield of 2.64% to investors and pays a quarterly dividend of $2.10 per share. Elevance Health pays 25.22% of its earnings as a dividend. UnitedHealth Group pays out 52.29% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios ELV or UNH?
Elevance Health quarterly revenues are $48.9B, which are smaller than UnitedHealth Group quarterly revenues of $109.6B. Elevance Health's net income of $2.2B is lower than UnitedHealth Group's net income of $6.3B. Notably, Elevance Health's price-to-earnings ratio is 15.07x while UnitedHealth Group's PE ratio is 13.34x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Elevance Health is 0.49x versus 0.72x for UnitedHealth Group. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ELVElevance Health0.49x 15.07x $48.9B $2.2B UNHUnitedHealth Group0.72x 13.34x $109.6B $6.3B
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is MSTR Stock Fundamentally Misunderstood?
Software firm turned Bitcoin treasury Strategy (NASDAQ:MSTR) has made waves…
Is Alphabet or Amazon the Better Buy?
Alphabet (NASDAQ:GOOG) and Amazon (NASDAQ:AMZN) are two of the mega-cap…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 41x
Buy
63
Is NVDA Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 49x
Sell
39
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
20
KARO alert for Jun 13
Karooooo [KARO] is up 1.11% over the past day.
Sell
18
OXM alert for Jun 13
Oxford Industries [OXM] is down 4.41% over the past day.
Sell
46
CRMT alert for Jun 13
America's Car-Mart [CRMT] is up 0.38% over the past day.
